由人工智能驱动的慢性病检测,集成TabNet和LSTM进行精确诊断
Winner Pulakhandam1, Visrutatma Rao Vallu2, Archana Chaluvadi3
1Personify Inc, Austin, TX, USA.
概括
这项研究引入了一种先进的AI系统,用于早期检测慢性病 (CKD). 这种新的方法结合了TabNet和LSTM,从复杂的患者数据中高精度诊断CKD.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 人工智能的人工智能
- 数据科学数据科学数据科学
背景情况:
- 慢性病 (CKD) 构成了全球重大健康挑战,需要早期检测才能有效管理.
- 目前的诊断方法面临复杂的CKD数据集的局限性,往往导致延迟干预.
- 现有的机器学习模型需要改进,以准确处理复杂的CKD数据.
研究的目的:
- 开发一种基于人工智能的先进系统,用于早期检测和诊断慢性病 (CKD).
- 创建一个能够高效处理和分析复杂医疗保健数据的系统,以改善CKD诊断.
- 通过利用复杂的人工智能技术来改进现有的诊断模型,以提高准确性和效率.
主要方法:
- 数据收集和预处理,包括预期最大化用于归算和单一类SVM用于异常值去除.
- 使用主要组件分析 (PCA) 减少尺寸,然后使用TabNet.Net进行特征选择.
- 利用长期短期记忆 (LSTM) 网络来捕捉患者数据中的时间依赖性,以检测异常.
主要成果:
- 人工智能系统实现了高性能指标:98.58%的准确性,98.89%的精度,98.24%的回忆率和98.56%的F1得分.
- 与XGBoost,SVM和KNN等现有方法相比,拟的模型表现出优越的性能.
- 该系统有效地减少了CKD检测中的假阳性和假阴性.
结论:
- 整合TabNet用于特征选择和LSTM用于顺序模式识别,为早期CKD检测提供了一个强大的框架.
- 这种人工智能驱动的方法在管理复杂的医疗数据方面取得了重大进展,以便及时准确地诊断CKD.
- 开发的系统提供了一个有希望的解决方案,通过早期和精确的诊断慢性病,改善患者的治疗结果.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
01:28Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
254
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
254
01:18Chronic Kidney Disease IV: Nursing Management
308
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
308
01:24Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
178
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178